Literature DB >> 32950424

Mice Are Not Humans: The Case of p53.

Martin Fischer1.   

Abstract

Mouse models represent powerful tools in cancer research that have influenced much of our understanding of tumor development and our current anticancer strategies. Yet, central signaling pathways differ considerably between mouse and human, including gene regulatory networks (GRNs) of the most important tumor suppressor p53 and its oncogenic sibling p63.
Copyright © 2020 The Author. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cancer research; evolution; gene regulatory networks; mouse models; p53; p63

Year:  2020        PMID: 32950424     DOI: 10.1016/j.trecan.2020.08.007

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  8 in total

1.  The Centriole's Role in Miscarriages.

Authors:  Tomer Avidor-Reiss; Luke Achinger; Rustem Uzbekov
Journal:  Front Cell Dev Biol       Date:  2022-03-01

2.  Charting oncogenicity of genes and variants across lineages via multiplexed screens in teratomas.

Authors:  Udit Parekh; Daniella McDonald; Amir Dailamy; Yan Wu; Thekla Cordes; Kun Zhang; Ann Tipps; Christian Metallo; Prashant Mali
Journal:  iScience       Date:  2021-09-20

Review 3.  Emerging Mechanisms of G1/S Cell Cycle Control by Human and Mouse Cytomegaloviruses.

Authors:  Boris Bogdanow; Quang Vinh Phan; Lüder Wiebusch
Journal:  mBio       Date:  2021-12-14       Impact factor: 7.867

4.  Direct cellular reprogramming enables development of viral T antigen-driven Merkel cell carcinoma in mice.

Authors:  Monique E Verhaegen; Paul W Harms; Julia J Van Goor; Jacob Arche; Matthew T Patrick; Dawn Wilbert; Haley Zabawa; Marina Grachtchouk; Chia-Jen Liu; Kevin Hu; Michael C Kelly; Ping Chen; Thomas L Saunders; Stephan Weidinger; Li-Jyun Syu; John S Runge; Johann E Gudjonsson; Sunny Y Wong; Isaac Brownell; Marcin Cieslik; Aaron M Udager; Arul M Chinnaiyan; Lam C Tsoi; Andrzej A Dlugosz
Journal:  J Clin Invest       Date:  2022-04-01       Impact factor: 14.808

5.  TargetGeneReg 2.0: a comprehensive web-atlas for p53, p63, and cell cycle-dependent gene regulation.

Authors:  Martin Fischer; Robert Schwarz; Konstantin Riege; James A DeCaprio; Steve Hoffmann
Journal:  NAR Cancer       Date:  2022-03-23

6.  p53-mediated AKT and mTOR inhibition requires RFX7 and DDIT4 and depends on nutrient abundance.

Authors:  Luis Coronel; David Häckes; Katjana Schwab; Konstantin Riege; Steve Hoffmann; Martin Fischer
Journal:  Oncogene       Date:  2021-12-14       Impact factor: 9.867

Review 7.  Drugging p53 in cancer: one protein, many targets.

Authors:  Ori Hassin; Moshe Oren
Journal:  Nat Rev Drug Discov       Date:  2022-10-10       Impact factor: 112.288

Review 8.  Mouse models for mesothelioma drug discovery and development.

Authors:  Kenneth P Seastedt; Nathanael Pruett; Chuong D Hoang
Journal:  Expert Opin Drug Discov       Date:  2020-12-31       Impact factor: 7.050

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.